WCM
COLL icon

Wedge Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Wedge Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Buy
71,523
+170
+0.2% +$5.81K 0.04% 289
2026
Q1 		$2.36M Buy
71,353
+13,092
+22% +$554K 0.04% 306
2025
Q4 		$2.7M Buy
+58,261
New +$2.44M 0.05% 294
2024
Q4 		– Sell
-43,503
Closed -$1.68M – 513
2024
Q3 		$1.68M Sell
43,503
-2,702
-6% -$96.4K 0.03% 349
2024
Q2 		$1.49M Buy
46,205
+3,089
+7% +$107K 0.03% 348
2024
Q1 		$1.67M Buy
43,116
+14,900
+53% +$521K 0.03% 343
2023
Q4 		$868K Hold
28,216
– – 0.02% 369
2023
Q3 		$631K Buy
+28,216
New +$644K 0.01% 390

Other funds holding COLL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Wedge Capital Management's COLL Position: Q2 2026 in Review

Wedge Capital Management increased its Collegium Pharmaceutical (COLL) stake by 0.24% in Q2 2026, buying an estimated $5.81K and bringing the position to 71,523 shares worth $2.59M. The position accounts for 0.04% of the portfolio, ranked #289.

Wedge Capital Management first reported a position in COLL in Q3 2023 and has held it in 8 quarters since. The position peaked at $2.7M in Q4 2025. 38 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Wedge Capital Management held 71,523 shares of Collegium Pharmaceutical worth $2.59M as of Q2 2026.
  • Wedge Capital Management bought 170 Collegium Pharmaceutical shares in Q2 2026, an estimated $5.81K.
  • Collegium Pharmaceutical made up 0.04% of Wedge Capital Management's portfolio in Q2 2026, its #289 holding.
  • Wedge Capital Management first reported a position in Collegium Pharmaceutical in Q3 2023 and has held it in 8 quarters since.
  • Wedge Capital Management's Collegium Pharmaceutical position peaked at $2.7M in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.